1,2,3,5-TETRAHYDROIMIDAZO(2,1-B)QUINAZOLINE
UNII Q1KQ4XFJ99

Substance Identification & Data

This profile provides standardized clinical and technical data for 1,2,3,5-tetrahydroimidazo(2,1-b)quinazoline, uniquely identified by the FDA Unique Ingredient Identifier (UNII) Q1KQ4XFJ99.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 32725-29-4 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
Q1KQ4XFJ99
CAS Registry Number
32725-29-4
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
1,2,3,5-TETRAHYDROIMIDAZO(2,1-B)QUINAZOLINE
Official standardized name for this substance within the FDA UNII nomenclature system.
InChIKey
C10H11N3
International Chemical Identifier digital signature for unique molecular identification.
SMILES String
DLLZYXWYSUGNDI-UHFFFAOYSA-N
Line notation for describing the chemical structure and connectivity of atoms.
PubChem CID
Unique identification number in the NCBI database of chemical substances.
Substance Type
chemical
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).
Ingredient Role
C1CN2Cc3c(cccc3)N=C2N1

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for 1,2,3,5-tetrahydroimidazo(2,1-b)quinazoline. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Systematic Nomenclature

1,2,3,5-TETRAHYDROIMIDAZO(2,1-B)QUINAZOLINE
2,3,5,10-TETRAHYDROIMIDAZO(2,1-B)QUINAZOLINE
IMIDAZO(2,1-B)QUINAZOLINE, 2,3,5,10-TETRAHYDRO-